Stocktwits on MSN

BNTX shares rise on Goldman Sachs upgrade, optimism for cancer portfolio

With a broad, strategic suite of programs, Goldman Sachs views BioNTech as “being at the nexus of significant developments ...
Fintel on MSN

Goldman Sachs upgrades BioNTech SE - Depositary Receipt (BNTX)

Fintel reports that on January 16, 2026, Goldman Sachs upgraded their outlook for BioNTech SE - Depositary Receipt ...

BioNTech (BNTX) Valuation Check As Shares Rebound Despite Longer Term Return Weakness

BioNTech (BNTX) has drawn fresh attention after recent share price moves, with the stock up around 9% over the past week and ...

Unpacking the Latest Options Trading Trends in BioNTech

Today, Benzinga's options scanner spotted 20 options trades for BioNTech. This is not a typical pattern. The sentiment among these major traders is split, with 55% bullish and 20% bearish. Among all ...